BioTroy Therapeutics Funding: $21M Raised, Series A (2025)
BioTroy Therapeutics is based in Shanghai, China. It has raised $21M in total funding. Latest round: Series A.
BioTroy Therapeutics funding overview
BioTroy Therapeutics is based in Shanghai, China. BioTroy Therapeutics has raised $21M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series A announced in June 2025. The round record for BioTroy Therapeutics runs through 2025; nothing later has been disclosed.
BioTroy Therapeutics at a glance
Total raised
$21M
Latest round
Series A
Latest round date
June 2025
Headquarters
Shanghai, China
Frequently asked about BioTroy Therapeutics funding
How much has BioTroy Therapeutics raised?
BioTroy Therapeutics has raised $21M in total disclosed funding across the rounds on record.
Who has invested in BioTroy Therapeutics?
No investors are named on the public record for BioTroy Therapeutics yet.
What was the latest BioTroy Therapeutics funding round?
The most recent disclosed round is a Series A, announced in June 2025.
Where is BioTroy Therapeutics based?
BioTroy Therapeutics is based in Shanghai, China.
When did BioTroy Therapeutics last raise?
The last disclosed BioTroy Therapeutics round closed in June 2025 at Series A.
Round data for BioTroy Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Shanghai and backer lists below.
